Literature DB >> 16641315

Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity.

Stefanie Prilla1, Jasmin Schrobang, John Ellis, Hans-Dieter Höltje, Klaus Mohr.   

Abstract

In general, the M2 subtype of muscarinic acetylcholine receptors has the highest sensitivity for allosteric modulators and the M5 subtype the lowest. The M2/M5 selectivity of some structurally diverse allosteric agents is known to be completely explained by M2 177Tyr and M2 423Thr in receptors whose orthosteric site is occupied by the conventional ligand N-methylscopolamine (NMS). This study explored the role of the conserved M2 422Trp and the adjacent M2 423Thr in the binding of alkane-bisammonio type modulators, gallamine, and diallylcaracurine V. Experiments were performed with human M2 or M5 receptors or mutants thereof. It was found that M2 422Trp and M2 423Thr independently influenced allosteric agent binding. The presence of M2 423Thr may enhance the affinity of binding, depending on the allosteric agent, either directly or indirectly (by avoiding sterical hindrance through its M5 counterpart 478His). Replacement of M2 422Trp and of the corresponding M5 477Trp by alanine revealed a pronounced contribution of these epitopes to subtype independent baseline affinity in NMS-bound and NMS-free receptors for all agents except diallylcaracurine V. In a few instances, this tryptophan also influenced cooperativity and subtype selectivity. Docking simulations using a three-dimensional M2 receptor model revealed that the aromatic rings of M2 177Tyr and M2 422Trp, in a concerted action, might fix one of the aromatic moieties of alkane-bisammonio compounds between them. Thus, M2 422Trp and the spatially adjacent M2 177Tyr, as well as M2 423Thr, form a cluster of amino acids within the allosteric binding cleft that is pivotal for both M2/M5 subtype selectivity and baseline affinity of allosteric agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641315     DOI: 10.1124/mol.106.023481

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

1.  Depolarization induces a conformational change in the binding site region of the M2 muscarinic receptor.

Authors:  Noa Dekel; Michael F Priest; Hanna Parnas; Itzchak Parnas; Francisco Bezanilla
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-19       Impact factor: 11.205

Review 2.  Emerging paradigms in GPCR allostery: implications for drug discovery.

Authors:  Denise Wootten; Arthur Christopoulos; Patrick M Sexton
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

3.  Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs.

Authors:  Ron O Dror; Hillary F Green; Celine Valant; David W Borhani; James R Valcourt; Albert C Pan; Daniel H Arlow; Meritxell Canals; J Robert Lane; Raphaël Rahmani; Jonathan B Baell; Patrick M Sexton; Arthur Christopoulos; David E Shaw
Journal:  Nature       Date:  2013-10-13       Impact factor: 49.962

4.  Dynamic ligand binding dictates partial agonism at a G protein-coupled receptor.

Authors:  Andreas Bock; Brian Chirinda; Fabian Krebs; Regina Messerer; Julia Bätz; Mathias Muth; Clelia Dallanoce; Dominika Klingenthal; Christian Tränkle; Carsten Hoffmann; Marco De Amici; Ulrike Holzgrabe; Evi Kostenis; Klaus Mohr
Journal:  Nat Chem Biol       Date:  2013-11-10       Impact factor: 15.040

5.  Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.

Authors:  Karen J Gregory; Nathan E Hall; Andrew B Tobin; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2010-01-05       Impact factor: 5.157

Review 6.  Rational design of dualsteric GPCR ligands: quests and promise.

Authors:  Klaus Mohr; Christian Tränkle; Evi Kostenis; Elisabetta Barocelli; Marco De Amici; Ulrike Holzgrabe
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

7.  Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.

Authors:  Alaa Abdul-Ridha; Laura López; Peter Keov; David M Thal; Shailesh N Mistry; Patrick M Sexton; J Robert Lane; Meritxell Canals; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

8.  Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor.

Authors:  Andreas Bock; Marcel Bermudez; Fabian Krebs; Carlo Matera; Brian Chirinda; Dominique Sydow; Clelia Dallanoce; Ulrike Holzgrabe; Marco De Amici; Martin J Lohse; Gerhard Wolber; Klaus Mohr
Journal:  J Biol Chem       Date:  2016-06-13       Impact factor: 5.157

9.  Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis.

Authors:  Thor Seneca Thorsen; Rachel Matt; William I Weis; Brian K Kobilka
Journal:  Structure       Date:  2014-10-23       Impact factor: 5.006

10.  Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.

Authors:  Katie Leach; Richard E Loiacono; Christian C Felder; David L McKinzie; Adrian Mogg; David B Shaw; Patrick M Sexton; Arthur Christopoulos
Journal:  Neuropsychopharmacology       Date:  2009-11-25       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.